| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Total assets | 607,836 | 674,281 | ||
| Accumulated other comprehensive income (loss) | 477 | 113 | ||
| Total shareholders' equity | 559,511 | 633,978 | ||
| Total liabilities and shareholders equity | 607,836 | 674,281 | ||
Xenon Pharmaceuticals Inc. (XENE)
Xenon Pharmaceuticals Inc. (XENE)